CA1027554A - PREPARATION OF 7.beta.-(.alpha.-ETHERIFIED OXIMINO) ACYLAMIDO-CEPH-3-EM-4-CARBOXYLIC ACIDS - Google Patents

PREPARATION OF 7.beta.-(.alpha.-ETHERIFIED OXIMINO) ACYLAMIDO-CEPH-3-EM-4-CARBOXYLIC ACIDS

Info

Publication number
CA1027554A
CA1027554A CA141,965A CA141965A CA1027554A CA 1027554 A CA1027554 A CA 1027554A CA 141965 A CA141965 A CA 141965A CA 1027554 A CA1027554 A CA 1027554A
Authority
CA
Canada
Prior art keywords
ceph
acylamido
em
beta
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA141,965A
Other languages
French (fr)
Other versions
CA141965S (en
Inventor
Janice Bradshaw
Martin C. Cook
Gordon I. Gregory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to GB1508271A priority Critical patent/GB1399086A/en
Priority to GB4588471 priority
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of CA1027554A publication Critical patent/CA1027554A/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26251025&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA1027554(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application status is Expired legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/14Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to heteroatoms, with at the most one to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54Radicals substituted by carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulfur with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
CA141,965A 1971-05-14 1972-05-12 PREPARATION OF 7.beta.-(.alpha.-ETHERIFIED OXIMINO) ACYLAMIDO-CEPH-3-EM-4-CARBOXYLIC ACIDS Expired CA1027554A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1508271A GB1399086A (en) 1971-05-14 1971-05-14 Cephalosporin compounds
GB4588471 1971-10-01

Publications (1)

Publication Number Publication Date
CA1027554A true CA1027554A (en) 1978-03-07

Family

ID=26251025

Family Applications (1)

Application Number Title Priority Date Filing Date
CA141,965A Expired CA1027554A (en) 1971-05-14 1972-05-12 PREPARATION OF 7.beta.-(.alpha.-ETHERIFIED OXIMINO) ACYLAMIDO-CEPH-3-EM-4-CARBOXYLIC ACIDS

Country Status (22)

Country Link
JP (3) JPS531280B1 (en)
AT (1) AT336786B (en)
BE (1) BE783449A (en)
CA (1) CA1027554A (en)
CH (1) CH591497A5 (en)
CS (2) CS245753B2 (en)
CY (1) CY971A (en)
DE (2) DE2223375C2 (en)
DK (1) DK155187C (en)
ES (2) ES402651A1 (en)
FR (2) FR2137900B1 (en)
GB (1) GB1399086A (en)
HK (1) HK66078A (en)
IE (1) IE38172B1 (en)
IL (1) IL39429A (en)
KE (1) KE2895A (en)
MY (1) MY7800466A (en)
NL (1) NL166688C (en)
NO (1) NO154797C (en)
PH (1) PH11205A (en)
SE (1) SE457795B (en)
YU (2) YU41807B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235896B1 (en) 1998-03-30 2001-05-22 Ranbaxy Laboratories Limited Process for the preparation of cefuroxime

Families Citing this family (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4064346A (en) * 1971-05-14 1977-12-20 Glaxo Laboratories Limited 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GB1445979A (en) * 1972-10-25 1976-08-11 Glaxo Lab Ltd Cephalosporin derivatives
AR208283A1 (en) * 1973-03-15 1976-12-20 Fujisawa Pharmaceutical Co A process for the preparation of derivatives of 2-alkyl-2-or 3-fefem-4-carboxylic acid
FI65258C (en) * 1973-12-21 1984-04-10 Glaxo Lab Ltd Foerfarande Foer framstaellning of a antibiotiskt verkande 7 eta acylamidocef-3-em-4-carboxylic acid
GB1512957A (en) * 1974-08-23 1978-06-01 Glaxo Lab Ltd Gephalosporin antibiotics
DK154939C (en) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade for preparing thiazolylacetamido-cephem compounds or pharmaceutically acceptable salts or esters thereof
GB1522140A (en) * 1974-12-20 1978-08-23 Glaxo Lab Ltd Syn-7-(2-hydroxyiminoacetamido)-3-pyridiniummethyl cephalosporins methods for their preparation and compositions containing them
NO760358L (en) * 1975-02-04 1976-08-05 Fujisawa Pharmaceutical Co
GB1555471A (en) * 1975-06-19 1979-11-14 Glaxo Lab Ltd 7 carbamoylalkoxyimino acetamido 3 em 4 carboxylic acidsand derivatives thereof
SE440655B (en) * 1976-01-23 1985-08-12 Roussel Uclaf Seen to be stella new oxime derivative of 7-amino-thiazolyl-acetamido-cephalosporanic
IE44888B1 (en) * 1976-03-09 1982-05-05 Fujisawa Pharmaceutical Co 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation theroef
FR2345153B1 (en) * 1976-03-25 1979-10-05 Roussel Uclaf
DK162391C (en) * 1976-04-12 1992-03-09 Fujisawa Pharmaceutical Co Analogifremgangsmaade for the production of syn-isomers of 3,7-disubstituted-3-cephem-4-carboxylic acid
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
DE2760484C2 (en) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid
FR2361895B1 (en) * 1976-08-20 1978-12-15 Roussel Uclaf
GB1592149A (en) * 1976-10-08 1981-07-01 Fujisawa Pharmaceutical Co 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof
FR2381053B1 (en) * 1977-02-18 1979-06-01 Roussel Uclaf
JPS623155B2 (en) * 1977-02-18 1987-01-23 Takeda Chemical Industries Ltd
FR2384779B1 (en) * 1977-03-25 1979-07-20 Roussel Uclaf
SE439312B (en) * 1977-03-25 1985-06-10 Roussel Uclaf Seen to be stella new oxime derivatives of 3-acetoxymethyl-7-thiol aminotiazolylacetamido
DE2714880A1 (en) * 1977-04-02 1978-10-26 Hoechst Ag Cephem derivatives and process for their manufacture
DE2716677C2 (en) * 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt, De
GB1599232A (en) * 1977-06-03 1981-09-30 Hoffmann La Roche 7-(2-oximinoacetamido)-cephalosporin derivatives
IT1192287B (en) * 1977-11-14 1988-03-31 Fujisawa Pharmaceutical Co of cephalosporanic acid derivatives to pharmaceutical action and related preparation process
SE445350B (en) * 1978-04-14 1986-06-16 Roussel Uclaf Oxime derivatives of 3-azidomethyl-7-amino-thiazolyl-acetamido-cephalosporanic acid and its priority over as antibiotics
DE2822861A1 (en) * 1978-05-26 1979-11-29 Hoechst Ag Cephem derivatives and process for their manufacture
AR228726A1 (en) * 1978-05-26 1983-04-15 Glaxo Group Ltd Process for the preparation of the antibiotic (6R, 7R) -7 - ((Z) -2- (2-aminothiazol-4-yl) -2- (2-carboxyprop-2-oxyimino) acetamido) -3- (1- pyridiniomethyl) ceph-3-em-4-carboxylate
DE2822860A1 (en) * 1978-05-26 1979-11-29 Hoechst Ag Cephem derivatives and process for their manufacture
US4268509A (en) * 1978-07-10 1981-05-19 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and processes for preparation thereof
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
FR2438051B2 (en) * 1978-10-05 1981-12-11 Roussel Uclaf
NO793688L (en) * 1978-11-15 1980-05-19 Glaxo Group Ltd A process for preparing cephalosporinderivater
EP0027599B1 (en) * 1979-10-12 1984-10-03 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
DE2914327A1 (en) * 1979-04-09 1980-10-30 Hoechst Ag Cephem derivatives and process for their manufacture
EP0088454B1 (en) * 1979-09-03 1986-03-05 Fujisawa Pharmaceutical Co., Ltd. New starting compounds for preparing cephem compounds and processes for their preparation
US4341777A (en) * 1979-09-10 1982-07-27 Glaxo Group Limited Cephalosporin antibiotic
EP0104671B1 (en) * 1980-02-18 1990-05-23 Roussel-Uclaf Oxime derivatives of 3-alkyloxy or 3-alkylthiomethyl-7-amino-thiazolylacetamido-cephalosporanic acid, their preparation, their use as medicines and compositions containing them
FR2476087B1 (en) * 1980-02-18 1983-07-18 Roussel Uclaf
FR2499995B1 (en) * 1981-02-13 1985-01-18 Roussel Uclaf
GR75644B (en) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
ZA8103787B (en) * 1980-06-18 1982-07-28 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
EP0037797A3 (en) * 1980-03-11 1981-12-16 Ciba-Geigy Ag Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application
IL63207A (en) * 1980-07-24 1985-09-29 Lonza Ag Process for the preparation of 2-(2-aminothiazole-4-yl)-2-(syn)-methoxyiminoacetic acid esters
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3175156D1 (en) * 1980-08-29 1986-09-25 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
US4416879A (en) * 1980-09-08 1983-11-22 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
US4458072A (en) * 1980-10-10 1984-07-03 Hoffmann-La Roche Inc. Acyl derivatives
FR2494274B2 (en) * 1980-11-20 1983-04-29 Rhone Poulenc Sante
FR2494279B1 (en) * 1980-11-20 1983-02-04 Rhone Poulenc Sante
FR2494276B2 (en) * 1980-11-20 1983-04-15 Rhone Poulenc Sante
FR2494275B2 (en) * 1980-11-20 1983-04-15 Rhone Poulenc Sante
FR2494280B1 (en) * 1980-11-20 1983-08-26 Rhone Poulenc Sante
GR76342B (en) * 1981-02-02 1984-08-06 Fujisawa Pharmaceutical Co
JPS6011917B2 (en) * 1981-04-09 1985-03-28 Yamanouchi Pharma Co Ltd
FR2505338B1 (en) * 1981-05-11 1983-07-18 Rhone Poulenc Sante
FR2505339B1 (en) * 1981-05-11 1983-07-18 Rhone Poulenc Sante
EP0070803A3 (en) * 1981-07-16 1984-05-02 Ciba-Geigy Ag Antibiotically active aminotriazolylcephalosporin derivatives and their preparation
RO84456B (en) * 1981-09-08 1984-08-30 Eli Lilly And Co Process for preparing thieno and furopyridinium substituted cephalosporin derivatives
JPH0526795B2 (en) * 1981-09-14 1993-04-19 Fujisawa Pharmaceutical Co
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
MA19602A1 (en) * 1981-09-30 1983-04-01 Ciba Geigy Ag Compounds amino oxazolyl, process for their preparation, pharmaceutical preparations containing these compounds and their application
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives
PH19163A (en) * 1982-04-06 1986-01-16 Daiichi Seiyaku Co Cephalosporin derivatives
US4500526A (en) * 1982-06-28 1985-02-19 Bristol-Myers Company Cephalosporin derivatives
DE3374410D1 (en) 1982-06-28 1987-12-17 Bristol Myers Co Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
GB2125033B (en) * 1982-07-23 1985-08-29 Servipharm Ltd Cephalosporins
IE55406B1 (en) * 1982-08-07 1990-09-12 Tanabe Seiyaku Co Novel cephalosporin compounds and preparation thereof
US4546101A (en) * 1982-09-10 1985-10-08 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds useful for treating infectious diseases in human being and animals and processes for preparation thereof
FR2533216B1 (en) * 1982-09-22 1985-03-29 Toyama Chemical Co Ltd
JPH0316102B2 (en) * 1982-10-19 1991-03-04 House Food Industrial Co
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
US4492693A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Benzothienylglycyl cephalosporin derivatives
US4482553A (en) * 1983-04-12 1984-11-13 Eli Lilly And Company Benzothienylglycyl cephalosporin derivatives
US4492694A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Indolylglycyl cephalosporin derivatives
EP0122155A3 (en) * 1983-04-12 1985-07-31 Eli Lilly And Company Improvements in or relating to naphthylglycyl cephalosporin derivatives
DE3330605A1 (en) * 1983-08-25 1985-03-14 Hoechst Ag Cephalosporin derivatives and process for their manufacture
JPS60190783A (en) * 1983-12-21 1985-09-28 Sumitomo Seiyaku Kk Cephem compound
JPS60132983A (en) * 1983-12-21 1985-07-16 Tanabe Seiyaku Co Ltd Thiazoleacetic acid derivative and its production
JPH0516437B2 (en) * 1983-12-29 1993-03-04 Mochida Pharm Co Ltd
DE3485860T2 (en) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporin compounds, processes for their manufacture and pharmazeutishe preparations.
GB8411954D0 (en) * 1984-05-10 1984-06-13 Glaxo Group Ltd Cephalosporin antibiotics
FI851934L (en) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
IE58487B1 (en) * 1984-09-07 1993-09-22 Kaisha Maiji Seika New cephalosporin compounds and the production thereof
US4868173A (en) * 1984-11-20 1989-09-19 Ici Pharma Cephalosporin derivatives
JPS61145186A (en) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd Novel cephem compound and preparation thereof
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
EP0186187B1 (en) * 1984-12-27 1992-02-26 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
US4814328A (en) * 1986-03-19 1989-03-21 Banyu Pharmaceutical Co., Ltd. Cephalosporin derivatives, and antibacterial agents
DE3623921A1 (en) * 1986-07-16 1988-01-21 Basf Ag Oxime ether and containing them fungicidal
ZA8707987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (en) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd Novel cephalosporin derivative, production thereof and antibacterial agent containing said derivative as active ingredient
EP0272827A3 (en) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-heterocyclicthiomethyl cephalosphorins
US5262410A (en) * 1986-12-23 1993-11-16 Ici Pharma 3-heterocyclic thiomethyl cephalosporins
US5189157A (en) * 1987-06-16 1993-02-23 Hoffmann La Roche Inc. Antibacterial cephalosporin compounds
DE3854684D1 (en) * 1987-07-23 1995-12-21 Zeneca Pharma Sa Cephalosporin compounds, processes for their preparation and pharmaceutical compositions containing them.
DE3854804D1 (en) * 1987-07-23 1996-02-01 Zeneca Pharma Sa Cephalosporin compounds, processes for their preparation and pharmaceutical compositions containing them
KR900006811B1 (en) * 1988-05-11 1990-09-21 허신구 Cephalosphorin derivatives and its process
US5202315A (en) * 1989-05-11 1993-04-13 Lucky, Ltd. Cephalosporin compounds
GB8927871D0 (en) * 1989-12-08 1990-02-14 Beecham Group Plc Novel compounds
AU2820700A (en) * 1999-03-09 2000-09-28 Ranbaxy Laboratories Limited Process for the preparation of cefuroxime

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE311519B (en) * 1962-12-14 1969-06-16 Astra Ab
GB1208014A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
GB1241657A (en) * 1967-08-21 1971-08-04 Glaxo Lab Ltd Improvements in or relating to cephalosporin compounds
GB1279402A (en) * 1968-06-14 1972-06-28 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
DK143853C (en) * 1971-01-29 1982-04-05 Glaxo Lab Ltd Analogifremgangsmaade for preparing the cephalosporin compounds or nontoxic salts or hydrates thereof
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235896B1 (en) 1998-03-30 2001-05-22 Ranbaxy Laboratories Limited Process for the preparation of cefuroxime

Also Published As

Publication number Publication date
NL7206403A (en) 1972-11-16
BE783449A1 (en)
DE2223375A1 (en) 1972-11-23
DE2265234A1 (en) 1976-12-30
NL166688B (en) 1981-04-15
FR2137899A1 (en) 1972-12-29
ES402651A1 (en) 1975-11-01
YU41807B (en) 1988-02-29
MY7800466A (en) 1978-12-31
JPS531280B1 (en) 1978-01-17
YU126772A (en) 1982-02-28
PH11205A (en) 1977-10-28
YU321379A (en) 1982-02-28
IL39429A (en) 1978-04-30
SE457795B (en) 1989-01-30
IL39429D0 (en) 1972-07-26
ATA420872A (en) 1976-09-15
CH591497A5 (en) 1977-09-30
CA1027554A1 (en)
NO154797C (en) 1986-12-29
ES430104A1 (en) 1976-10-01
HK66078A (en) 1978-11-24
FR2137899B1 (en) 1976-08-20
CS245753B2 (en) 1986-10-16
NL166688C (en) 1985-01-16
IE38172L (en) 1972-11-14
DE2265234C2 (en) 1983-02-10
BE783449A (en) 1972-11-13
IE38172B1 (en) 1978-01-18
FR2137900B1 (en) 1976-04-16
DE2223375C2 (en) 1985-05-15
CS245754B2 (en) 1986-10-16
JPS54135792A (en) 1979-10-22
CY971A (en) 1978-12-22
KE2895A (en) 1978-11-10
JPS5328141A (en) 1978-03-16
DK155187B (en) 1989-02-27
FR2137900A1 (en) 1972-12-29
NO154797B (en) 1986-09-15
AT336786B (en) 1977-05-25
JPS6324993B2 (en) 1988-05-23
GB1399086A (en) 1975-06-25
DK155187C (en) 1989-07-17

Similar Documents

Publication Publication Date Title
CA999203A (en) Body-retained catheter
CA986512A (en) Chromophore-substituted vinyl-halomethyl-s-triazines
CA996117A (en) 1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and esters, and their preparation
CA978204A (en) Hydrocyanation of olefins
CA1002531A (en) Derivatives of 2-oxa-1,1,3-propanetricarboxylic acid and 2-oxa-1,1,3,3-propanetetracarboxylic acid
CA994194A (en) Catheter assembly
CA956556A (en) Nut member
CA966828A (en) 1.alpha.-HYDROXYCHOLECALCIFEROL AND PROCESS OF MAKING SAME
JPS57203082A (en) Manufacture of substituted-4-oxo-4h-1- benzopyran-2-carboxylic acids
AU6781074A (en) Pharmaceutical compositions
CA1012972A (en) 4-LITHIO-.alpha.-ISOPROPENYL-2-OXOAZETIDINE-1-ACETIC ACID COMPOUNDS
CA1003408A (en) Preparation of dipeptide-alkylesters
CA1001991A (en) Glyoxilic acid preparation
CA991363A (en) Bleaching assistants and preparation thereof
CA972212A (en) High protein composition
AU4146772A (en) Cyclopropane derivatives and biologically active compositions thereof
CA986248A (en) Process for the preparation of substantially linear polyesters of low free carboxyl group content
CA970642A (en) Multi-beater thresher
CA1027554A (en) PREPARATION OF 7.beta.-(.alpha.-ETHERIFIED OXIMINO) ACYLAMIDO-CEPH-3-EM-4-CARBOXYLIC ACIDS
CA987342A (en) Manufacture of unsaturated nitriles
CA1005437A (en) .alpha.-THIOUREIDOCEPHALOSPORANIC ACID COMPOUNDS
CA980773A (en) .beta.-HALOGENOETHYL-METHYL-SILANES
CA973445A (en) Deflocculating compositions
CA979891A (en) N(6)-aralkyl-adenosine derivatives and process for the preparation thereof
CA957192A (en) Disk harrow